| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0162 | 17-hydroxywortmannin | Irreversible inhibitor of PI3K and mTOR |
|
| DCC0163 | 17ß-hsd2-in-24 | Novel potent inhibitor of 17ß-hydroxysteroid dehydrogenase type 2 (17ß-HSD2) |
|
| DCC0164 | 17β-hsd1 Inhibitor 1 | Novel inhibitor of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1), being highly selective over 17β-HSD2 |
|
| DCC0165 | 18bioder | Novel Neuroprotective GSK-3β Inhibitor, highly selectively inhibiting HIV-1; The second generation derivative of 6BIO |
|
| DCC0166 | 1-benzyl-i3c | Highly potent inhibitor of Wnt/βcatenin signaling in melanoma cells, coordinately inhibiting cell proliferation and disrupts expression of Microphthalmia Associated Transcription Factor isoform M, also inhibiting NEDD4-1 |
|
| DCC0167 | 1-deoxy-d-allulose | Strong growth inhibitor as an antimetabolite |
|
| DCC0168 | 1-hex-6azglcnac | Reporter molecule functionalized at the anomeric position, exhibiting robust labeling over background with negligible amounts of nonspecific chemical labeling in cell lysates |
|
| DCC0169 | 1-hex-glcnalk | Reporter molecule functionalized at the anomeric position, exhibiting robust labeling over background with negligible amounts of nonspecific chemical labeling in cell lysates |
|
| DCC0170 | 1h-thieno[2,3-d]pyrimidine-2,4-dione | Building Block |
|
| DCC0171 | 1h-thieno[3,2-d]pyrimidine-2,4-dione | Building Block |
|
| DCC0172 | 1h-thieno[3,4-d]pyrimidine-2,4-dione | Building Block |
|
| DCC0173 | 1-nitro-2-phenylethane | The first organic NO2-containing molecule isolated from plants, stimulating the soluble guanylate cyclase-cGMP pathway |
|
| DCC0174 | 1ß-hydroxy Vitamin D3 | inactive isomeric impurity of Alphacalcidol |
|
| DCC0175 | 2,2'-dioh-5,5'-dif-dppen | Novel inhibitor of thioredoxin reductase (TrxR) |
|
| DCC0176 | 2,3-acbt 1p | Novel potent antiangiogenic agent, binding to VEGFR2, significantly reducing neovascularization in both ex vivo and in vivo angiogenic assays without affecting the proliferation of endothelial cells |
|
| DCC0177 | 2',3'-dihydroxypuberulin | Natural Inhibitor for FcεRI expression on mast cell from Verbasucum thapsus L |
|
| DCC0178 | 2,3-dmb-pp1 | Inhibitor of SykM442A S505A ASKA- (analog-sensitive kinase alleles) mediated cellular calcium flux |
|
| DCC0179 | 2,4-bis(p-hydroxyphenyl)-2-butenal | Concentration- and time-dependent inhibitor of the growth of NSCLC cells inducing apoptosis |
|
| DCC0180 | 2,4-dichloroamphetamine Hcl | Stimulator of the central nervous system, decreasing the 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels in brain |
|
| DCC0181 | 2,5-2f-kbz | Novel Versatile Probe for Interrogating Histone Benzoylation and Interactions in Living Cells |
|
| DCC0182 | 24(s),25-epoxycholesterol | Oxysterol agonist of the liver X receptor |
|
| DCC0183 | 24(s)-saringosterol | Novel Selective LXRβ Agonist |
|
| DCC0184 | 27-caua | Novel selective inhibitor of EGFR kinase, leading to inactivation of PI3K/AKT/mTOR and Ras-Raf-MEK-ERK signal pathways |
|
| DCC0185 | 2-ampp | Novel GPR88 Agonist |
|
| DCC0186 | 2b182c | Novel potent activator of both human and mouse TLR4-NF-κB reporter cells and primary cells, inducing serum anti-HA and anti-NA IgG1 levels |
|
| DCC0187 | 2-bispeb | Metabotropic Glutamate Receptor 5-selective Negative Allosteric Modulator |
|
| DCC0188 | 2ccpa Sodium | Lipid mediator, regulates neuronal apoptosis in traumatic brain injury (TBI) |
|
| DCC0189 | 2-cl-8-ma-camp | Site BI- selective synergistic activator of PKA I |
|
| DCC0190 | 2-cldg | Inhibitor of cellular glycosylation; Analytical standard |
|
| DCC0191 | 2'-deoxy-adpr | Endogenous superagonist of transient receptor potential melastatin 2 (TRPM2) |
|
